Risk Factors for Developing Skeletal‐Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone‐Modifying Agents
2016 ◽
Vol 21
(4)
◽
pp. 508-513
◽
Ryota Tanaka
◽
Kan Yonemori
◽
Akihiro Hirakawa
◽
Fumie Kinoshita
◽
Naoki Takahashi
◽
...
2018 ◽
Vol 11
◽
pp. 38-50
◽
Hongwei Zhang
◽
Wei Zhu
◽
Ewelina Biskup
◽
Weige Yang
◽
Ziang Yang
◽
...
D Lüftner
◽
V Lorusso
◽
I Duran
◽
G Hechmati
◽
C Garzon-Rodriguez
◽
...
M Yong
◽
CF Christiansen
◽
H Gammelager
◽
C Sværke
◽
V Chia
◽
...
2020 ◽
Vol 31
◽
pp. S1265
S.L. Anwar
◽
W.S. Avanti
◽
R. Cahyono
◽
L. Choridah
◽
W.A. Harahap
◽
...
M. Yong
◽
A. Jensen
◽
J. Jacobsen
◽
M. Nørgaard
◽
J. Fryzek
◽
...
A. Stopeck
◽
R. de Boer
◽
Y. Fujiwara
◽
M. Lichinitser
◽
K. Tonkin
◽
...
2014 ◽
Vol 25
◽
pp. iv125
R. Tanaka
◽
K. Yonemori
◽
A. Hirakawa
◽
J. Hashimoto
◽
M. Kodaira
◽
...
2009 ◽
Vol 18
(2)
◽
pp. 197-203
◽
Mateya Trinkaus
◽
Christine Simmons
◽
Jeff Myers
◽
George Dranatisaris
◽
Mark Clemons